Track topics on Twitter Track topics that are important to you
OncBioMune Pharmaceuticals Inc OncBioMune, formerly Quint Media Inc is a biopharmaceutical company that develops novel cancer immunotherapy products. The company's products comprise biosimilars and vaccines developed for various cancer types such as breast, prostrate, renal and ovarian cancer. Its lead product ProscaVax, a therapeutic vaccine is developed for prostate cancer patients; and OvcaVax for treating ovarian cancer. The company utilizes Targeted Transferrin Transport Technology to deliver cytotoxic agents targeted selectively to the cancer cell, and reduce effect on normal cells. It attacks iron metabolism of cancer cells and prevent iron storage into the protein ferritin with its technology. The company also has a portfolio of targeted therapies including paclitaxel. OncBioMune is headquartered in Baton Rouge, Louisiana, the US.
OncBioMune Pharmaceuticals Inc Key Recent Developments
Jun 28,2017: OncBioMune Pharmaceuticals Establishes Another Revenue Stream; Schedules First Patient with AAT Deficiency for Treatment in Mexico
Mar 27,2017: OncBioMune Sales of Bekunis and Cirkused Exceed Forecast by 164 Percent in First Six Months on Market
Oct 24,2016: Immunotherapy Expert Dr. Brian Barnett Joins OncBioMune Scientific Advisory Board
Oct 07,2016: OncBioMune Pharmaceuticals Announces Shareholder Update
Mar 22,2016: Dr. J. Jacques Carter Joins OncBioMune Pharmaceuticals Scientific Advisory Board
This comprehensive SWOT profile of OncBioMune Pharmaceuticals Inc provides you an indepth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData's Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of OncBioMune Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. excluding weekends.
The profile contains critical company information including*, x000D
Business description A detailed description of the company's operations and business divisions.x000D
Corporate strategy Analyst's summarization of the company's business strategy.x000D
SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.x000D
Company history Progression of key events associated with the company.x000D
Major products and services A list of major products, services and brands of the company.x000D
Key competitors A list of key competitors to the company.x000D
Key employees A list of the key executives of the company.x000D
Executive biographies A brief summary of the executives' employment history.x000D
Key operational heads A list of personnel heading key departments/functions.x000D
Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.x000D
Key manufacturing facilities A list of key manufacturing facilities of the company.x000D
Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.x000D
Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.x000D
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,x000D
You get detailed information about the company and its operations to identify potential customers and suppliers.x000D
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.x000D
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.x000D
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events. x000D
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.x000D
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.x000D
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.x000D
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.x000D
Gain key insights into the company for academic or business research.x000D
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...